Maastricht University Medical Center: Carcinoma, Basal Cell trials

The registry lists 18 Carcinoma, Basal Cell studies with Maastricht University Medical Center as lead sponsor. 6 are open to participants now and 0 have results posted.

Phase 2 2Phase 3 2Phase 4 1No phase 14(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Real-world Evaluation of the Implementation of LC-OCT in Daily Clinical PracticeRecruitingNCT07501780
• D-OCT for Detection and Subtyping of BCC: a Diagnostic Cohort StudyNot yet recruitingNCT06273722
• Remote Assessment of OCT Scans for BCC DetectionNot yet recruitingNCT06273709
• Real-world Evaluation of Diagnostic and Treatment Strategies in Low-Risk Basal Cell CarcinomaRecruitingNCT06252857
• AI-aided Optical Coherence Tomography for the Detection of Basal Cell CarcinomaRecruitingNCT05817279
• Oral Hedgehog Inhibitors in the Treatment of Basal Cell Carcinoma in the Netherlands: a Prospective Registration StudyRecruitingNCT05463757
• cOCT Versus LC-OCT for Diagnosing Basal Cell Carcinoma: a Diagnostic Cohort StudyActive, not recruitingNCT06024629
• Complications and Recurrences After Mohs Micrographic Surgery and Slow MohsActive, not recruitingNCT06014619
• Training Health Care Professional in Detecting BCC on OCT Using E-learning and CUSUM-analysisCompletedNCT05634421
• A Patient Decision Aid for Patients With Superficial Basal Cell CarcinomaCompletedNCT05628714
• Added Value of OCT for Diagnosing Recurrent BCC After Non-invasive TreatmentCompletedNCT05581342Not applicable
• Optical-Coherence Tomography for the Non-invasive Diagnosis and Subtyping of Basal Cell CarcinomaStatus unknownNCT05041777
• (Cost)-Effectiveness of Optical Coherence Tomography (OCT) in Basal Cell Carcinoma (BCC)Status unknownNCT03848078Not applicable
• Surgery Versus Combined Treatment With Curettage and Imiquimod for Nodular Basal Cell CarcinomaStatus unknownNCT02242929Phase 3
• Topical Green Tea Ointment in Treatment of Superficial Skin CancerCompletedNCT02029352Phase 2/3
• Superficial Basal Cell Carcinoma Treatment With Topical Photodynamic Therapy With Fractionated 5-aminolevulinic Acid 20% Versus Two Stage MethylaminolevulinateStatus unknownNCT01491711Phase 4
• Clinical Diagnosis of Basal Cell Carcinoma SubtypeCompletedNCT01370824
• Topical Vitamin D3, Diclofenac or a Combination of Both to Treat Basal Cell CarcinomaCompletedNCT01358045Phase 2